HHL-B:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Others |

Last Closing

CAD 8.18

Change

-0.01 (-0.12)%

Market Cap

N/A

Volume

200.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.21 (+0.61%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.01 (+0.03%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.53 (-2.06%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.15 (+0.40%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.01 (-0.02%)

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.58 (+1.17%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.92 (+3.29%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.19 (+1.72%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.17 (+0.76%)

CAD 2.78B

ETFs Containing HHL-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.91% 8% B- 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.91% 7% C- 11% F
Trailing 12 Months  
Capital Gain -10.89% 8% B- 15% F
Dividend Return 4.53% 86% B+ 80% B-
Total Return -6.36% 9% A- 16% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.07% 51% F 46% F
Dividend Return 4.02% 51% F 42% F
Total Return 0.94% 76% C+ 36% F
Risk Return Profile  
Volatility (Standard Deviation) 5.91% 74% C 88% B+
Risk Adjusted Return 67.93% 74% C 75% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike